MRI scan to personalize radiation for esophageal cancer
Part of Cancer, Digestive system clinical trials.
This Phase 1 study uses specialized imaging (including MRI) to better “see” low-oxygen areas in esophageal cancer and help guide individualized radiation treatment. It aims to improve how radiation is planned and delivered while checking safety.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have esophageal cancer.
- Your doctor plans you for radiation plus chemotherapy (either before or as the main treatment).
- Your general health/activity is fairly good (ECOG score 0 to 2).
- You can complete the study’s treatment plan and sign informed consent.
- You can safely have an MRI (not too claustrophobic, and no non–MRI-safe metal or devices).
- You can safely receive the study imaging materials (no prior severe allergic reaction to the contrast or imaging medicines).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a special MRI technique to see if it can predict how well esophageal cancer responds to chemo-radiotherapy before surgery. It may help doctors choose the best treatment plan for you.
This study tests a combination of targeted radiation (SBRT) and immunotherapy for people with esophageal cancer that has spread to a few spots in the body. The goal is to see if this approach helps control the cancer and improves your well-being.
This study uses repeated MRI scans during radiation treatment to see how tumors change. It may help doctors adjust treatment and improve outcomes for many types of cancer.
This trial uses a special PET/CT scan to see how well your esophageal cancer responds to chemotherapy and radiation. It helps doctors find out if the treatment is working early on.
This study looks at whether CT and MRI scans taken before and after chemotherapy or radiation can help doctors predict how well the treatment is working and what the cancer looks like after surgery. It may help improve treatment plans for people with esophageal cancer.
This trial tests a personalized approach using MRI to guide chemotherapy and radiation, combined with immunotherapy, for advanced esophageal cancer that cannot be removed by surgery or has spread to nearby lymph nodes. It aims to improve treatment effectiveness while managing side effects.
Hear when a new Esophageal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.